Insiders · Profile

Virani Shafique

Chief Business Officer at RECURSION PHARMACEUTICALS. Filing since 16 Aug 2022. CIK 0001856081

Company
Date
Role
Action
Shares
Amount
Of holding
16 Jan 2024
Chief Business Officer
Sold on a plan
18,000
$196.74K
11.6%
15 Dec 2023
Chief Business Officer
Sold on a plan
18,000
$172.80K
11.6%
15 Nov 2023
Chief Business Officer
Sold on a plan
18,000
$117.18K
11.4%
16 Oct 2023
Chief Business Officer
Sold on a plan
18,000
$113.40K
11.4%
15 Sep 2023
Chief Business Officer
Sold on a plan
18,000
$155.88K
11.4%
15 Aug 2023
Chief Business Officer
Sold on a plan
18,000
$166.50K
11.4%
26 Jul 2023
Chief Business Officer
Sold on a plan
20,000
$288.20K
12.2%
25 Jul 2023
Chief Business Officer
Sold on a plan
20,000
$286.00K
12.2%
18 Jul 2023
Chief Business Officer
Sold on a plan
30,000
$412.20K
17.2%
17 Jul 2023
Chief Business Officer
Sold on a plan
30,000
$351.60K
17.2%
16 Jun 2023
Chief Business Officer
Sold on a plan
30,000
$282.30K
17.2%
15 Jun 2023
Chief Business Officer
Sold on a plan
30,000
$290.10K
17.2%
2 Jun 2023
Chief Business Officer
Sold on a plan
17,865
$159.53K
11.0%
1 Jun 2023
Chief Business Officer
Sold on a plan
25,000
$214.50K
13.4%
16 Feb 2023
Chief Business Officer
Sold, plan not stated
1,768
$14.89K
0.9%
15 Feb 2023
Chief Business Officer
Sold, plan not stated
7,486
$62.36K
3.8%
17 Jan 2023
Chief Business Officer
Sold, plan not stated
10,000
$91.56K
12.0%
15 Dec 2022
Chief Business Officer
Sold, plan not stated
10,000
$88.53K
11.3%
15 Nov 2022
Chief Business Officer
Sold, plan not stated
10,000
$123.12K
10.7%
14 Oct 2022
Chief Business Officer
Sold, plan not stated
10,000
$109.18K
10.1%
15 Sep 2022
Chief Business Officer
Sold, plan not stated
10,000
$133.63K
9.6%
16 Aug 2022
Chief Business Officer
Sold, plan not stated
30,000
$378.44K
23.3%
22 decisions on file.